MEDICAL ENGINEERING & PHYSICS, published by Elsevier Science Ltd, is an esteemed journal in the fields of Biomedical Engineering and Biophysics. With an ISSN of 1350-4533 and an E-ISSN of 1873-4030, it has established itself as a significant resource from its inception in 1994, continuing to deliver pivotal research up to 2024. This journal, categorized in the Q3 quartile for both Biomedical Engineering and Biophysics, holds a respectable position in Scopus rankings, boasting its relevance in the upper echelons of academic inquiry, particularly ranking #75/152 in Biophysics and #158/303 in Biomedical Engineering. Authors and researchers in these dynamic fields will find the journal’s rigorous peer-review process and commitment to publishing high-quality original research invaluable for advancing their work. Although the journal is not open access, it continues to attract submissions that push the boundaries of innovation and application in medical technologies, making it an essential resource for anyone dedicated to the integration of engineering principles with medical sciences.

Journal of Medical Biochemistry is a distinguished peer-reviewed journal published by the SOC MEDICAL BIOCHEMISTS SERBIA, focusing on the significant intersection of biochemistry and medicine. With an e-ISSN of 1452-8266, this Open Access journal has been enriching the academic community since 2007, providing vital insights and research findings that advance the field of medical biochemistry. Based in Belgrade, Serbia, the journal plays a pivotal role in disseminating contemporary research, highlighted by its impressive standings in the 2023 quartile rankings, featuring Q2 in Medical Biochemistry and Q3 in Clinical Biochemistry. The journal is recognized in Scopus with rankings that position it within the discerning area of medical biochemistry and clinical biochemistry, attesting to its influence and relevance. By promoting innovative research and facilitating an open exchange of scientific ideas, the Journal of Medical Biochemistry is a crucial resource for researchers, professionals, and students dedicated to uncovering the biochemical underpinnings essential to improving human health.

The Journal of Mechanics in Medicine and Biology, published by World Scientific Publishing Co Pte Ltd, serves as a critical platform for interdisciplinary research at the intersection of engineering and biomedical sciences. With an ISSN of 0219-5194 and E-ISSN of 1793-6810, this esteemed journal has been dedicated to exploring the mechanical principles that govern biological systems since its inception in 2008. Based in Singapore, it addresses a diverse range of topics, from biomaterials to biomechanics, contributing valuable insights into the field’s evolving landscape. Although currently positioned in Q4 of Biomedical Engineering according to the 2023 category quartiles, it is poised for growth and increased visibility within the scientific community, fostering innovation and collaboration among researchers, professionals, and students alike. The journal emphasizes the importance of cutting-edge research and its practical implications, making it a vital resource for those striving to enhance the future of medical technologies and biological understanding.

Bone & Joint Research is a prestigious open access journal published by the British Editorial Society of Bone & Joint Surgery, which has been serving the orthopedic and surgical community since its inception in 2012. With an impact factor reflecting its high standards and relevance within the field, this journal boasts impressive Scopus rankings, positioning it in the Q1 category for both Orthopedics and Sports Medicine and Surgery as of 2023. Located in the United Kingdom, the journal aims to disseminate cutting-edge research, clinical studies, and innovative approaches to treatment in musculoskeletal health, making it an indispensable resource for researchers, healthcare professionals, and students alike. The journal encourages a collaborative discourse that fosters advancements in the understanding and treatment of bone and joint diseases, fulfilling its mission to enhance patient outcomes and improve the quality of care.

The Journal of Orthopaedic Translation is a leading peer-reviewed publication dedicated to advancing the field of orthopedics through innovative research and clinical implications. Published by Elsevier and available as an Open Access journal since 2013, it ensures that cutting-edge insights and findings are accessible to a global audience, promoting collaboration and knowledge sharing among researchers, professionals, and students. With an impressive impact factor, the journal has achieved a remarkable Q1 ranking in the categories of Orthopedics and Sports Medicine, placing it in the top 1% of journals in this highly specialized field. As of 2023, it ranks #5 out of 321 in conjunction with a notable 98th percentile achievement in Scopus Ranks, underscoring its reputation for excellence and relevance. Through a focus on both basic and applied research, the Journal of Orthopaedic Translation aims to bridge the gap between laboratory and clinical practice, contributing significantly to the evolving landscape of orthopedic health. Join us in exploring the transformative studies shaping the future of patient outcomes and surgical interventions.

Biomedical Engineering Online, published by BMC, is an esteemed open-access journal in the United Kingdom that has been advancing the field of biomedical engineering since its inception in 2002. With a commitment to disseminating high-quality research, the journal encompasses a broad scope, including innovative studies in biomaterials, imaging technologies, and medical applications. Recognized within the Q2 quartile for various categories such as Biomaterials and Biomedical Engineering, it ranks favorably among its peers: Rank #58 out of 333 in Radiology, and Rank #15 out of 63 in Radiological and Ultrasound Technology in the Scopus database. These rankings, coupled with an open-access model, ensure that critical advancements in medical technology are accessible to researchers, health professionals, and students globally. As it continues through its converged years from 2002 to 2024, Biomedical Engineering Online remains an invaluable resource for anyone involved in the cutting-edge intersection of engineering and medicine.

Cellular and Molecular Bioengineering, published by SPRINGER, is a prominent journal dedicated to the exploration of interdisciplinary approaches in the fields of biochemistry, genetics, and molecular biology. With an ISSN of 1865-5025 and an E-ISSN of 1865-5033, this journal has been a pivotal resource since its inception in 2009, showcasing groundbreaking research that combines innovative modeling and simulation techniques with cellular and molecular applications. As a Q2 journal in both Biochemistry, Genetics and Molecular Biology (miscellaneous) and Modeling and Simulation categories, it ranks favorably in the Scopus metrics, placing 62nd out of 324 in Mathematics_ Modeling and Simulation, and 69th out of 221 in General Biochemistry, Genetics and Molecular Biology. The journal's commitment to quality research and its contribution to advancing academic dialogue make it essential for researchers, professionals, and students seeking to stay at the forefront of bioengineering innovation. While it currently does not offer open access, it continues to provide significant insights and empirical studies that can help shape future developments in the field, reinforcing its role as a key player in cellular and molecular bioengineering.

Bioengineering & Translational Medicine, published by WILEY, positions itself at the forefront of innovation in the fields of biomedical engineering, biotechnology, and pharmaceutical science. With an impressive impact factor reflected through its top-tier Q1 rankings in multiple categories, the journal serves as a critical platform for disseminating cutting-edge research and stimulating discourse among professionals and scholars since its establishment as an open-access journal in 2016. Key to its mission is facilitating the translation of bioengineering research into tangible medical applications, thereby enhancing healthcare outcomes. With its comprehensive scope, it attracts a diverse readership, including researchers, industry leaders, and students eager to engage with the latest developments in translational medicine. The journal operates under robust access options, ensuring that research is freely available for maximum reach and impact, fostering collaboration and innovation across disciplines worldwide.

IN VIVO is a prestigious academic journal published by the International Institute of Anticancer Research, dedicated to advancing the fields of biochemistry, genetics, molecular biology, cancer research, and pharmacology. With its ISSN 0258-851X and E-ISSN 1791-7549, this journal has been a key contributor to innovative research since its inception in 1987, providing a crucial platform for the dissemination of significant findings in its scope. With an impressive impact reflected in its quartile rankings (Q2 in Biochemistry, Genetics and Molecular Biology and Medicine; Q3 in Cancer Research and Pharmacology), IN VIVO reaches a global audience comprising researchers, health professionals, and students. Although it operates on a subscription basis, the journal’s commitment to scientific excellence and rigorous peer review ensures that all published works maintain high quality and relevance. Notably positioned in Scopus ranks within the 36th to 59th percentiles across various categories, IN VIVO continues to be a vital resource for cutting-edge research and developments, solidifying its importance within the scientific community.

JOR Spine is a premier open access journal published by WILEY, focusing on advancing the field of orthopedics and sports medicine. With its ISSN 2572-1143 and E-ISSN 2572-1143, the journal has rapidly gained recognition since its inception in 2018, reflecting the high-quality research being disseminated within the academic community. It holds an impressive rank of #41 out of 321 in the Scopus classification for Medicine, specifically within Orthopedics and Sports Medicine, placing it in the 87th percentile—an indicator of its substantial contribution to the field. As a Q1 journal in its category as of 2023, JOR Spine is committed to publishing rigorous research that enhances clinical practice and informs future studies. The journal’s open access model ensures that critical findings are accessible to a global audience of researchers, practitioners, and students, fostering collaboration and innovation in spine research. With regular issues and an array of article types reflecting contemporary advancements, JOR Spine serves as an essential resource for anyone involved in the spine care continuum.